(Q28327767)

English

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine

scientific article published on December 2, 1992

In more languages

edit

Statements

instance of

scholarly article

0 references

title

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine (English)

0 references

main subject

multiple drug resistance

0 references

tamoxifen

0 references

phase I clinical trial

0 references

1 reference

2

D. C. Smith

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1359155

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359155

retrieved

18 September 2022

author name string

D. L. Trump

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1359155

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359155

retrieved

18 September 2022

P. G. Ellis

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1359155

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359155

retrieved

18 September 2022

M. P. Rogers

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1359155

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359155

retrieved

18 September 2022

S. C. Schold

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1359155

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359155

retrieved

18 September 2022

E. P. Winer

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1359155

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359155

retrieved

18 September 2022

T. J. Panella

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1359155

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359155

retrieved

18 September 2022

V. C. Jordan

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1359155

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359155

retrieved

18 September 2022

R. L. Fine

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1359155

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1359155

retrieved

18 September 2022

language of work or name

English

0 references

publication date

2 December 1992

0 references

published in

Journal of the National Cancer Institute

0 references

volume

84

0 references

issue

23

0 references

page(s)

1811-6

0 references

Identifiers

DOI

10.1093/JNCI/84.23.1811

0 references

PubMed publication ID

1359155

0 references

(Q28327767)

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)